103 related articles for article (PubMed ID: 25497015)
1. Osteopontin-integrin α(v)β(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma.
Nakamura T; Shinriki S; Jono H; Ueda M; Nagata M; Guo J; Hayashi M; Yoshida R; Ota T; Ota K; Kawahara K; Nakagawa Y; Yamashita S; Nakayama H; Hiraki A; Shinohara M; Ando Y
FEBS Lett; 2015 Jan; 589(2):231-9. PubMed ID: 25497015
[TBL] [Abstract][Full Text] [Related]
2. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
4. Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes.
Harada K; Ferdous T; Ueyama Y
Int J Oncol; 2014 Apr; 44(4):1302-8. PubMed ID: 24452635
[TBL] [Abstract][Full Text] [Related]
5. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
Chiu YW; Tu HF; Wang IK; Wu CH; Chang KW; Liu TY; Kao SY
Oral Oncol; 2010 Apr; 46(4):302-6. PubMed ID: 20219412
[TBL] [Abstract][Full Text] [Related]
6. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma.
Luo SD; Chen YJ; Liu CT; Rau KM; Chen YC; Tsai HT; Chen CH; Chiu TJ
Biomed Res Int; 2015; 2015():508587. PubMed ID: 26491674
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.
Nakagawa Y; Nakayama H; Nagata M; Yoshida R; Kawahara K; Hirosue A; Tanaka T; Yuno A; Matsuoka Y; Kojima T; Yoshitake Y; Hiraki A; Shinohara M
Int J Oncol; 2014 Apr; 44(4):1376-84. PubMed ID: 24452447
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of drug transporter expression by osteopontin in prostate cancer cells.
Hsieh IS; Huang WH; Liou HC; Chuang WJ; Yang RS; Fu WM
Mol Pharmacol; 2013 May; 83(5):968-77. PubMed ID: 23434829
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.
Cui R; Takahashi F; Ohashi R; Gu T; Yoshioka M; Nishio K; Ohe Y; Tominaga S; Takagi Y; Sasaki S; Fukuchi Y; Takahashi K
Lung Cancer; 2007 Sep; 57(3):302-10. PubMed ID: 17482311
[TBL] [Abstract][Full Text] [Related]
11. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
[TBL] [Abstract][Full Text] [Related]
12. The role of the osteopontin-integrin αvβ3 interaction at implantation: functional analysis using three different in vitro models.
Kang YJ; Forbes K; Carver J; Aplin JD
Hum Reprod; 2014 Apr; 29(4):739-49. PubMed ID: 24442579
[TBL] [Abstract][Full Text] [Related]
13. The tumour stromal features are associated with resistance to 5-FU-based chemoradiotherapy and a poor prognosis in patients with oral squamous cell carcinoma.
Matsuoka Y; Yoshida R; Nakayama H; Nagata M; Hirosue A; Tanaka T; Kawahara K; Nakagawa Y; Sakata J; Arita H; Hiraki A; Shinohara M
APMIS; 2015 Mar; 123(3):205-14. PubMed ID: 25639735
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9.
Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
Am J Pathol; 2014 Mar; 184(3):842-58. PubMed ID: 24412090
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
[TBL] [Abstract][Full Text] [Related]
17. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.
Yang M; Luo Q; Chen X; Chen F
J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534
[TBL] [Abstract][Full Text] [Related]
18. Integrin αvβ3 expression in tongue squamous carcinoma cells Cal27 confers anticancer drug resistance through loss of pSrc(Y418).
Stojanović N; Brozovic A; Majhen D; Bosnar MH; Fritz G; Osmak M; Ambriović-Ristov A
Biochim Biophys Acta; 2016 Aug; 1863(8):1969-78. PubMed ID: 27108184
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity.
Devoll RE; Li W; Woods KV; Pinero GJ; Butler WT; Farach-Carson MC; Happonen RP
J Oral Pathol Med; 1999 Mar; 28(3):97-101. PubMed ID: 10069535
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma.
Nagata M; Nakayama H; Tanaka T; Yoshida R; Yoshitake Y; Fukuma D; Kawahara K; Nakagawa Y; Ota K; Hiraki A; Shinohara M
Br J Cancer; 2011 Oct; 105(9):1322-30. PubMed ID: 21952624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
